Veracyte (VCYT) Securities Investigation Notice - Levi & KorsinskyVeracyte (VCYT) Securities Investigation Notice - Levi & Korsinsky Levi & Korsinsky, LLP Nov 12, 2026, 10:09 ET Needham reportedly cut its Veracyte price target by $23 per share after the Company's November 4, 2026 outlook reset on its Decipher Prostate test. An investigation into potential securities law violations is underway on behalf of VCYT shareholders who lost money. NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Needham reportedly cut its ...